Selegiline
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01037 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | unipolar depression | TxGNN Knowledge Graph |
| 2 | endogenous depression | TxGNN Knowledge Graph |
| 3 | early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph |
| 4 | parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph |
| 5 | major depressive disorder | TxGNN Knowledge Graph |
| 6 | X-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph |
| 7 | hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph |
| 8 | anxiety disorder | TxGNN Knowledge Graph |
| 9 | atypical juvenile parkinsonism | TxGNN Knowledge Graph |
| 10 | juvenile onset Parkinson disease 19A | TxGNN Knowledge Graph |
| 11 | Parkinson disease | TxGNN Knowledge Graph |
| 12 | hereditary late onset Parkinson disease | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.